4//SEC Filing
BHAGWAT DILEEP 4
Accession 0000909518-09-000164
CIK 0001208261other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:18 PM ET
Size
6.1 KB
Accession
0000909518-09-000164
Insider Transaction Report
Form 4
EPICEPT CORPEPCT
BHAGWAT DILEEP
SVP-Pharmaceutical Development
Transactions
- Award
Stock Option (right to buy)
2009-02-20+130,000→ 615,965 totalExercise: $0.56Exp: 2019-02-20→ Common Stock, par value $0.0001 per share (130,000 underlying)
Footnotes (2)
- [F1]The options shall vest in increments upon the achievement of each of the following business objectives: the completion of a Ceplene marketing agreement(s); the completion of a licensing agreement for NP-1; obtaining market approval for Ceplene in the United States; and obtaining market approval for Ceplene in Canada. The exercise of these options is subject to shareholder approval of an increase in the number of shares available under the 2005 Equity Incentive Plan.
- [F2]No consideration was given since option was granted pursuant to a stock option agreement.
Documents
Issuer
EPICEPT CORP
CIK 0001208261
Entity typeother
Related Parties
1- filerCIK 0001141757
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:18 PM ET
- Size
- 6.1 KB